| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.14B | 43.95B | 41.87B | 40.30B | 38.81B | 40.14B |
| Gross Profit | 9.70B | 9.86B | 9.48B | 9.32B | 9.22B | 8.80B |
| EBITDA | 5.87B | 5.88B | 5.27B | 5.46B | 5.67B | 5.40B |
| Net Income | 1.54B | 1.70B | 1.63B | 1.71B | 1.78B | 1.64B |
Balance Sheet | ||||||
| Total Assets | 68.49B | 70.46B | 68.70B | 65.14B | 69.23B | 63.56B |
| Cash, Cash Equivalents and Short-Term Investments | 8.08B | 10.29B | 8.94B | 10.85B | 14.73B | 7.55B |
| Total Debt | 19.86B | 21.54B | 20.06B | 18.72B | 23.86B | 19.36B |
| Total Liabilities | 33.28B | 34.89B | 34.53B | 32.31B | 37.58B | 32.14B |
| Stockholders Equity | 33.96B | 34.27B | 33.05B | 32.50B | 31.34B | 31.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 395.64M | 650.17M | 1.95B | 3.73B | 108.64M |
| Operating Cash Flow | 0.00 | 4.53B | 3.55B | 4.58B | 4.57B | 4.47B |
| Investing Cash Flow | 0.00 | -3.55B | -4.96B | -2.38B | -840.19M | -4.33B |
| Financing Cash Flow | 0.00 | -46.84M | -474.94M | -6.05B | 3.45B | 1.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥547.04B | 13.65 | 6.55% | 2.71% | -0.06% | 137.47% | |
77 Outperform | ¥116.71B | 14.56 | 7.53% | 3.01% | 5.44% | 45.99% | |
76 Outperform | ¥76.90B | 12.49 | ― | 6.64% | 2.85% | -9.13% | |
73 Outperform | ¥82.36B | 13.19 | ― | 3.31% | 0.83% | -9.16% | |
70 Outperform | ¥19.39B | 13.58 | ― | 4.39% | 5.06% | -15.22% | |
70 Outperform | ¥159.38B | 7.06 | 10.46% | 2.35% | 4.56% | 49.23% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |